Illumina, Inc. vs Teradyne, Inc. — how do they compare? Illumina, Inc. trades at $192.47 (market cap $27.94B), while Teradyne, Inc. trades at $374.17 (market cap $52.25B). The key difference: Teradyne, Inc. is the larger of the two by market cap, and Teradyne, Inc. pays a 0.16% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | TER | |
|---|---|---|
Market Cap | $27.94B | $52.25B |
Sector | Health | Technology |
52-Week High | $194.33 | $483.84 |
52-Week Low | $91.00 | $90.15 |
Enterprise Value | $29.33B | $52.08B |
Dividend Yield | — | 0.16% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.
Read more on TER →